DDB2 and hepatocellular carcinoma: It is speculated that the DDB2 SNP rs1050244 may interfere with the targeted interaction of miRNAs (miR-133a and miR197), resulting in the upregulation of DDB2 mRNA expression, thereby reducing an individual’s susceptibility to HCC.